genet
epidemiolog
includ
twin
studi
provid
robust
evid
genet
variat
human
popul
contribut
suscept
infecti
diseas
one
major
limit
studi
attempt
identifi
gene
mechan
underli
suscept
lack
power
caus
small
sampl
size
develop
novel
technolog
burgeon
inform
human
genom
hapmap
project
human
genet
divers
begin
new
era
studi
genet
complex
diseas
review
look
afresh
epidemiolog
evid
support
role
genet
suscept
infecti
diseas
examin
somewhat
limit
achiev
date
discuss
current
advanc
methodolog
technolog
potenti
lead
translat
data
futur
lancet
infect
di
infect
one
lead
caus
human
mortal
morbid
much
burden
fall
children
infecti
diseas
major
select
pressur
gene
involv
immun
respons
numer
divers
human
genom
indic
evolutionari
advantag
vari
immunolog
respons
wide
rang
infecti
pathogen
obviou
hla
loci
prototyp
candid
genet
region
infecti
diseas
suscept
exampl
individu
class
ii
hla
allel
heterozyg
like
clear
hepat
b
infect
heterozyg
class
allel
progress
hiv
aidsdefi
ning
ill
slowli
lower
mortal
convers
scenario
increas
hla
homozygos
may
contribut
increas
suscept
infect
genet
isol
popul
huge
variat
individu
outcom
follow
exposur
potenti
lifethreaten
pathogen
diff
erenti
suscept
partli
show
function
genet
divers
immun
respons
provid
overview
human
genet
suscept
infecti
diseas
review
support
epidemiolog
evid
discuss
current
methodolog
technolog
issu
highlight
somewhat
limit
achiev
date
especi
increas
understand
outcom
treatment
respons
specifi
c
infecti
diseas
suscept
infect
mani
human
diseas
includ
diabet
ischaem
heart
diseas
aris
complex
interact
environment
host
genet
factor
gener
mani
genet
loci
make
modest
contribut
human
diseas
suscept
ie
genet
complex
focu
fi
eld
identifi
loci
eff
ect
infect
condit
howev
mani
singlegen
mendelian
disord
aff
ect
immun
function
primari
immunodefi
cienci
report
although
often
rare
profound
immunodefi
cienci
stem
major
function
aberr
singl
gene
highli
inform
immunolog
mechan
protect
specifi
c
infect
also
import
exampl
common
singlegen
disord
markedli
infl
uenc
infectionspecifi
c
suscept
best
known
protect
aff
ord
sickl
cell
heterozygos
falciparum
malaria
variant
duff
antigen
gene
promot
result
lack
erythrocyt
surfac
express
prevent
bind
plasmodium
vivax
therefor
protect
recent
genet
variant
determin
blood
group
secretor
statu
shown
mediat
suscept
norwalk
viru
also
aff
ect
hiv
progress
independ
chemokin
variant
substanti
expect
increas
understand
genet
determin
diff
erenti
suscept
outcom
would
rapidli
translat
novel
therapi
prevent
intervent
much
expect
yet
realis
partli
methodolog
limit
earlier
studi
tendenc
examin
individu
gene
isol
without
consider
genet
environment
milieu
thu
mani
report
genet
associ
replic
subsequ
studi
understand
sceptic
exist
much
genet
epidemiolog
approach
actual
reveal
genet
basi
complex
diseas
howev
mani
recent
advanc
technolog
andmor
latterlyit
applic
studi
identifi
ed
import
protect
pathogen
pathway
led
individu
target
antiinfect
therapi
hope
enter
era
well
design
studi
begin
deliv
robust
genet
data
mani
opportun
translat
better
treatment
idea
human
genet
may
contribut
understand
suscept
infecti
review
diseas
new
earli
centuri
diff
erenti
suscept
infect
suggest
characterist
host
diseas
tuberculosi
leprosi
believ
inherit
defect
infecti
diseas
like
phenotyp
may
exhibit
famili
aggreg
greater
frequenc
diseas
rel
infect
individu
compar
rel
without
diseas
studi
famili
aggreg
therefor
investig
import
share
determin
environment
genet
diseas
suscept
usual
use
form
recurr
risk
ratio
essenti
ratio
preval
rel
index
case
preval
gener
popul
import
studi
diseas
phenotyp
care
defi
ned
particularli
context
infecti
diseas
interpret
recurr
risk
straightforward
phenotyp
binari
dichotom
trait
eg
presenc
absenc
meningococc
septicaemia
qualit
rang
clinic
phenotyp
may
less
consist
eg
measur
sever
infect
determin
treatment
intervent
famili
aggreg
measur
make
supposit
caus
aggreg
recurr
risk
within
gener
sibl
risk
ratio
identifi
share
environment
genet
eff
ect
infecti
diseas
transmiss
pathogen
famili
member
may
increas
risk
diseas
contribut
observ
phenotyp
aggreg
exampl
studi
sibl
recurr
risk
ratio
meningococc
diseas
time
increas
risk
infect
sibl
case
compar
gener
popul
risk
risk
decreas
longer
time
interv
index
case
sibl
case
recurr
risk
meningococc
diseas
sibl
time
popul
risk
index
sibl
case
occur
week
apart
fall
risk
year
elaps
case
data
indic
signifi
cant
genet
determin
meningococc
suscept
also
import
common
acquisit
virul
strain
within
famili
account
immedi
increas
risk
household
contact
studi
twin
also
provid
estim
rel
contribut
share
gene
environ
diseas
phenotyp
compar
risk
genet
ident
monozygot
twin
pair
dizygot
twin
share
averag
half
gene
twin
studi
infecti
diseas
histor
determin
zygos
diseas
phenotyp
may
inaccur
notwithstand
reserv
suscept
infect
show
markedli
increas
concord
monozygot
compar
dizygot
twin
exampl
includ
tuberculosi
sinus
helicobact
pylorispecifi
c
antibodi
titr
leprosi
recent
twin
triplet
data
indic
suscept
acut
chronic
otiti
media
larg
genet
determin
rel
contribut
infect
atopi
craniofaci
anatomi
determin
part
genet
factor
remain
unclear
twin
studi
may
also
provid
use
insight
determin
diseas
outcom
carrier
statu
hepat
b
viru
febril
respons
acquisit
plasmodium
falciparum
indic
increas
concord
monozygot
twin
pair
studi
sever
common
childhood
infect
use
hospit
admiss
phenotyp
indic
distinct
genet
factor
like
involv
diff
erent
infect
sinc
risk
admiss
second
twin
increas
twin
infecti
diagnosi
burgner
unpublish
concord
rate
common
otolaryngolog
procedur
myringotomi
adenotonsillectomi
surrog
diseas
sever
also
show
greatli
increas
concord
monozygot
twin
pair
burgner
unpublish
twin
studi
vaccin
respons
antigen
stimulu
unambigu
indic
signifi
cant
genet
infl
uenc
humor
cellmedi
respons
detail
genet
studi
indic
import
hla
nonhla
loci
vaccin
respons
studi
vitro
twin
fi
rstdegre
rel
also
show
import
genet
factor
determin
innat
immun
respons
infecti
stimuli
twin
studi
h
pylori
acquisit
compar
concord
rate
twin
rear
either
togeth
apart
gave
similar
measur
genet
infl
uenc
set
account
diseas
risk
howev
twin
sibl
commonli
rear
togeth
make
diffi
cult
teas
rel
contribut
genet
factor
share
environ
mental
exposur
particularli
pathogen
share
intergener
studi
may
circumv
issu
semin
studi
compar
risk
share
caus
prematur
mortal
children
adopt
earli
life
biolog
adopt
parent
risk
adopt
child
die
infect
increas
almost
six
time
biolog
parent
also
die
prematur
infect
wherea
increas
risk
observ
adopt
parent
die
infect
suggest
genet
rather
environment
factor
import
determin
infecti
diseas
mortal
much
smaller
genet
eff
ect
note
cardiovascular
diseas
malign
epidemiolog
data
indic
genet
factor
infl
uenc
suscept
outcom
review
infect
variou
studi
design
methodolog
issu
import
interpret
previou
data
design
contemporari
futur
studi
infect
fundament
genet
epidemiolog
recent
review
detail
brief
overview
provid
terminolog
explain
briefl
panel
note
although
singl
nucleotid
polymorph
snp
workhors
current
highthroughput
genotyp
technolog
form
genet
variat
also
common
human
genom
may
import
eff
ect
diseas
risk
includ
repeat
sequenc
motif
microsatellit
minisatellit
insert
delet
diff
erenc
gene
copi
number
exampl
recent
data
indic
strong
invers
correl
number
copi
hiv
suppress
chemokin
gene
hiv
suscept
essenti
two
type
studi
designgenomewid
candid
genethat
use
localis
gene
underli
human
diseas
genomewid
studi
advantag
supposit
made
gene
involv
potenti
novel
unconsid
gene
may
identifi
ed
typic
genomewid
approach
use
linkag
studi
multipli
aff
ect
infect
pedigre
identifi
region
entir
genom
transmit
parent
spring
often
expect
independ
inherit
typic
aff
ect
sibl
pair
larger
multicas
pedigre
avail
recruit
inherit
region
genom
defi
ned
hundr
microsatellit
marker
main
disadvantag
linkag
studi
suffi
cient
number
aff
ect
sibl
pair
may
diffi
cult
recruit
mani
infect
linkag
studi
often
insensit
pick
rel
small
contribut
individu
genet
region
typic
complex
diseas
infect
exampl
success
genom
scan
undertaken
use
linkag
analysi
infecti
diseas
includ
intens
infect
schistosoma
mansoni
suscept
h
pylori
leprosi
associ
data
linkag
studi
replic
diff
erent
popul
case
may
repres
fals
discoveri
rate
inher
problem
studi
make
multipl
statist
comparison
increasingli
clear
mani
complex
diseas
show
genet
heterogen
diff
erent
genet
determin
diseas
oper
diff
erent
ethnic
group
exampl
mutat
locu
import
suscept
determin
infl
ammatori
bowel
diseas
white
popul
eff
ectiv
absent
asian
popul
phenotyp
genomewid
associ
studi
whole
genom
interrog
use
hundr
thousand
snp
recent
becom
realiti
genotyp
technolog
analyt
tool
evolv
approach
potenti
detect
subtl
genet
eff
ect
classic
linkag
studi
present
studi
use
million
approxim
million
estim
snp
human
genom
unresolv
panel
defi
nition
genet
terminolog
allel
associ
statist
analysi
determin
whether
diseas
associ
particular
allel
variant
one
loci
usual
compar
marker
allel
frequenc
diseas
group
control
group
statist
describ
individu
subpopul
whole
popul
structur
use
assess
evid
select
compar
frequenc
allel
diff
erent
popul
haplotyp
combin
marker
allel
diff
erent
marker
along
chromosom
tend
inherit
unit
snp
act
defi
ning
marker
haplotyp
virtu
linkag
disequilibrium
analys
haplotyp
tag
rather
variant
haplotyp
reduc
redund
genotyp
cost
measur
genet
divers
within
popul
statist
analysi
localis
gene
marker
respect
genom
base
recombin
frequenc
linkag
analysi
also
use
map
diseas
phenotyp
relat
polymorph
marker
nonrandom
associ
allel
two
neighbour
loci
inherit
togeth
often
expect
chanc
provid
basi
haplotyp
linkag
disequilibrium
map
associ
potenti
deriv
popul
admixtur
polymorph
characteris
variabl
number
tandem
repeat
often
defi
ned
number
repeat
row
least
two
nucleotid
use
marker
famili
linkag
studi
determin
person
uniqu
dna
fi
ngerprint
forens
medicin
also
known
ssr
simpl
sequenc
repeat
str
simpl
tandem
repeat
recent
combin
two
previous
distinct
popul
unknown
admixtur
may
result
spuriou
genet
associ
casecontrol
studi
design
singl
nucleotid
polymorph
singl
basepair
chang
specifi
c
point
genom
array
technolog
allow
larg
number
million
snp
genotyp
singl
array
typic
size
microscop
slide
eg
aff
ymetrix
illumina
addit
use
refer
burton
et
al
malat
calafel
calafel
malat
review
issu
particularli
relat
optimum
densiti
locat
snp
marker
genecentr
evenli
space
genom
implic
much
genom
studi
truli
cover
well
concern
regard
sampl
size
power
genomewid
associ
studi
high
fals
discoveri
rate
replic
independ
popul
essenti
current
report
genomewid
associ
studi
infecti
diseas
although
studi
underway
particular
studi
undertaken
banner
wellcom
trust
casecontrol
consortium
look
case
control
eight
complex
diseas
includ
tuberculosi
malaria
two
import
infecti
diseas
twostag
strategi
propos
snp
chip
panel
use
genotyp
case
control
region
posit
follow
least
anoth
case
control
one
biggest
project
ever
undertaken
identifi
genet
variat
may
predispos
peopl
protect
complex
diseas
hope
identifi
genet
signpost
research
abl
understand
peopl
risk
also
produc
eff
ectiv
treatment
genomewid
associ
approach
use
smaller
scale
noninfecti
genet
complex
diseas
exampl
genotyp
almost
snp
across
genom
identifi
ed
region
chromosom
associ
myocardi
infarct
map
identifi
ed
novel
function
polymorph
lymphotoxin
alpha
lta
gene
within
region
relat
function
variant
ligand
lta
odd
ratio
associ
lta
mutat
order
magnitud
expect
complex
diseas
anoth
studi
snp
chip
use
compar
case
agerel
macular
degener
control
identifi
major
gene
complement
factor
h
determin
suscept
common
intron
snp
among
snp
genotyp
strongli
associ
diseas
nomin
p
valu
less
correct
multipl
test
genotyp
rel
risk
homozyg
individu
ci
resequenc
reveal
polymorph
linkag
disequilibrium
risk
allel
caus
tyrosin
histidin
chang
amino
acid
complement
factor
h
protein
number
case
control
studi
small
increas
possibl
fals
posit
result
although
rel
risk
high
compar
usual
expect
complex
diseas
importantli
snpchip
studi
immedi
support
two
studi
use
four
independ
casecontrol
popul
studi
provid
major
conceptu
breakthrough
term
approach
made
novel
technolog
feasibl
recent
public
phase
hapmap
data
phase
ii
releas
http
wwwhapmap
org
main
practic
object
hapmap
project
identifi
set
snp
linkag
disequilibrium
subset
genotyp
socal
haplotypetag
snp
genomewid
associ
studi
thu
reduc
overal
amount
genotyp
requir
phase
data
involv
genotyp
million
snp
unrel
individu
parentchild
trio
nigerian
european
chines
japanes
descent
phase
ii
extend
million
snp
phase
data
alreadi
provid
mani
predict
test
applic
haplotyp
tag
across
popul
optimum
sampl
twostag
test
strategi
whole
genom
associ
studi
commerci
avail
snp
chip
work
best
predict
previou
studi
greater
densiti
snp
chip
requir
captur
haplotyp
divers
african
popul
compar
european
chines
japanes
popul
greater
divers
shorter
region
linkag
disequilibrium
observ
former
factor
import
applic
technolog
infecti
diseas
associ
studi
africa
nevertheless
case
control
nomin
p
valu
phase
hapmap
eg
newli
releas
sentrix
human
genotyp
beadchip
illimuna
one
snp
everi
kb
retain
power
detect
associ
due
common
causal
allel
african
popul
compar
roughli
european
chines
japanes
popul
snp
chip
aff
ymetrix
made
releas
phase
hapmap
haplotypetag
snp
inform
power
illumina
human
chip
ie
contain
two
tag
per
haplotyp
although
probabl
mani
whole
genom
associ
studi
futur
date
studi
complex
diseas
includ
infect
adopt
candid
gene
approach
choic
candid
gene
may
come
anim
data
result
wholegenom
studi
clinic
data
simpli
biolog
plausibl
import
methodolog
consider
approach
includ
follow
adequ
densiti
marker
candid
gene
ensur
studi
suffi
cient
sensit
exclud
genet
region
narrow
consist
phenotyp
defi
nition
match
case
control
sampl
size
power
candid
gene
studi
use
casecontrol
approach
unrecognis
ethnic
diff
erenc
group
probabl
result
spuriou
genet
associ
unrel
diseas
interest
exampl
probabl
strong
associ
review
hla
region
chopstick
use
sydney
impli
hla
region
necessarili
infl
uenc
manual
dexter
like
hla
type
identifi
es
asian
subpopul
issu
popul
stratifi
cation
like
confound
small
genet
eff
ect
sought
larg
popul
howev
confound
minimis
case
control
care
match
presenc
genet
admixtur
also
quantifi
ed
genet
data
allow
stratifi
ed
analys
sampl
size
permit
paediatr
popul
altern
approach
use
parent
genet
control
aff
ect
spring
approach
intrins
less
power
casecontrol
design
sinc
parent
control
enrich
genet
variant
interest
allow
inclus
famili
mix
ethnic
potenti
pool
data
across
ethnic
group
signifi
cant
genet
heterogen
present
probabl
crucial
overlook
methodolog
issu
sampl
size
power
genet
eff
ect
individu
genet
variant
usual
modest
genet
model
mode
inherit
often
unknown
frequenc
diseasemodifi
variant
may
vari
almost
studi
complex
diseas
genet
date
underpow
power
calcul
fi
gure
indic
excess
casecontrol
pair
casepar
trio
need
provid
adequ
power
especi
eff
ect
size
odd
ratio
expect
genet
contribut
complex
diseas
suscept
probabl
small
lack
power
owe
small
sampl
size
make
diffi
cult
interpret
current
previou
data
genet
suscept
infect
reason
attempt
critic
apprais
valu
judgment
past
present
studi
provid
comprehens
tabl
webtabl
list
studi
undertaken
date
commonli
studi
infecti
diseaseshiv
mycobacteri
infect
leprosi
tuberculosi
malaria
leishmaniasi
wherea
loci
eg
hla
class
class
ii
class
iii
allel
featur
repeatedli
within
diseas
formal
metaanalys
smaller
studi
yet
undertaken
determin
may
indic
statist
reliabl
associ
one
interest
observ
number
candid
gene
studi
focus
protein
involv
innat
recognit
microb
fi
rstline
defenc
innat
immun
pathway
tabl
underscor
like
select
pressur
exert
infecti
diseas
key
gene
regul
acquir
immun
respons
also
featur
candid
gene
multipl
infecti
diseas
tabl
studi
also
suff
er
lack
statist
power
requir
replic
valid
immun
respons
gene
highli
polymorph
cluster
genom
indic
evolutionari
pressur
select
formal
attempt
search
signal
evolutionari
select
c
trio
casecontrol
pair
power
calcul
diff
erent
frequenc
risk
allel
sampl
trio
casecontrol
pair
power
approxim
trio
standard
transmiss
disequilibrium
test
made
use
method
knapp
theoret
power
detect
allel
associ
made
assum
multipl
model
result
given
fi
rst
approxim
percentag
power
detect
allel
associ
power
calcul
essenti
ident
similar
size
casecontrol
sampl
advantag
trio
infl
uenc
popul
admixtur
advantag
casecontrol
analysi
one
third
less
genotyp
obtain
equival
power
graph
show
trio
casecontrol
pair
poor
power
detect
allel
associ
even
rel
common
risk
allel
frequenc
sampl
trio
casecontrol
pair
good
power
risk
allel
frequenc
sampl
trio
casecontrol
pair
improv
power
rare
risk
allel
frequenc
see
onlin
webtabl
recent
undertaken
gene
relat
immun
function
almost
common
snp
success
genotyp
across
gene
three
popul
sampl
independ
chromosom
utah
resid
european
ancestri
han
chines
guangxi
yoruba
peopl
southwest
nigeria
sampl
overlap
ident
use
hapmap
project
evid
select
base
four
test
nonneutr
evolut
assess
percentag
snp
within
locu
low
minor
allel
frequenc
percentag
high
minor
allel
frequenc
assess
frequenc
deriv
nonancestr
allel
comparison
f
st
panel
versu
heterozygos
rel
extend
haplotyp
homozygos
test
allel
frequenc
three
gene
stood
lie
cluster
relat
gene
encod
interleukin
chromosom
implic
mani
infecti
diseas
studi
tabl
webtabl
encod
protein
respons
determin
abo
blood
protein
secretor
statu
variat
gene
may
protect
respiratori
pathogen
h
pylori
encod
one
caveolin
protein
function
scaff
old
structur
cholesterolrich
lipid
raft
enhanc
immun
cell
function
involv
pathogen
entri
host
cell
rel
extend
haplotyp
homozygos
test
provid
best
evid
select
highlight
multidrug
resist
protein
implic
resist
streptococcu
pneumonia
mice
genet
determin
obvious
act
genet
environment
context
fact
often
ignor
genet
epidemiolog
studi
previous
regard
environ
someth
annoy
genet
variant
may
substanti
increas
risk
avian
infl
uenza
sever
hundr
time
person
carri
variant
never
encount
infl
uenza
requir
addit
polymorph
diff
erent
gene
function
eff
ect
fi
rst
variant
may
clinic
relev
fi
eld
genet
epidemiolog
increasingli
acknowledg
import
complex
biolog
interact
understand
genet
determin
genegen
interact
epistasi
describ
hiv
infect
hla
class
allel
associ
rapid
progress
aid
individu
also
carri
specifi
c
natur
killer
cell
kir
receptor
geneenviron
interact
shown
spontan
preterm
labour
infl
ammatori
basi
although
genet
variat
tumour
necrosi
factor
tnfa
gene
associ
increas
risk
preterm
labour
risk
increas
signifi
cantli
presenc
bacteri
vaginosi
independ
risk
outcom
cystic
fi
brosi
carri
function
variant
mannosebind
lectin
mbl
wors
pulmonari
outcom
replac
mbl
therapi
report
mbldefi
cient
cystic
fi
brosi
patient
surprisingli
mbl
exert
protect
eff
ect
innat
immunolog
eff
ect
recent
small
studi
mbl
defi
cienci
aff
ect
lung
function
associ
staphylococcu
aureu
colonis
exampl
geneenviro
interact
despit
increas
bodi
robust
data
identifi
genet
determin
infecti
diseas
illumin
key
biolog
pathway
move
bench
bedsid
infecti
diseas
fi
eld
remain
larg
unrealis
often
made
predict
worthi
except
function
genet
variat
cytochrom
system
seem
mediat
effi
caci
h
pylori
erad
eff
ect
proton
pump
inhibitor
metabol
strike
eleg
exampl
pharmacogenet
hiv
medicin
hypersensit
nucleosid
revers
transcriptas
inhibitor
abacavir
previous
limit
use
analysi
mhc
led
identifi
cation
particular
hla
haplotyp
greatli
increas
risk
abacavir
hypersensit
map
localis
function
variant
peptidebind
groov
heat
shock
protein
lie
central
mhc
genotyp
individu
variant
commenc
abacavir
cost
eff
ectiv
hope
exampl
clinic
relev
pharmacogenet
infecti
diseas
report
face
increas
antimicrobi
resist
fall
pharmaceut
enthusiasm
new
antibiot
develop
disappoint
track
record
adjunct
biolog
therapi
sever
sepsi
develop
novel
vaccin
pharmacogenet
intervent
remain
among
import
goal
genet
studi
infecti
diseas
suscept
declar
confl
ict
interest
data
review
identifi
ed
search
pubm
medlin
current
content
refer
relev
articl
numer
articl
identifi
ed
search
extens
fi
le
author
search
term
includ
combin
suscept
genet
suscept
herit
twin
genet
genet
epidemiolog
infect
infecti
diseas
well
term
specifi
c
infect
eg
malaria
gene
gene
product
eg
mannos
bind
lectin
eg
pubm
search
term
hiv
polymorph
drug
fi
eld
text
word
limit
human
date
languag
restrict
set
search
